Garlic supplementation and hyperlipidemia:
In a review of 29 randomized controlled trials, Garlic in comparison with placebo was associated with a significant reduction in levels of total cholesterol (the difference between the average in the garlic groups and the control groups was -0.19 mmol/L) and triacylglycerol (-0.11 mmol/L). LDL cholesterol lipoprotein and HDL cholesterol were not affected by garlic supplementation. (96)
Compared to placebo, garlic supplementation did not significant change levels of total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride or apolipoprotein B (used to evaluate the risk for cardiovascular disease). This review included 13 randomized controlled trials (n=1,056) with treatment length varying from 12 weeks to 24 weeks. (97)
Next Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137